Comparison of Fentanyl-Lignocaine versus Dexmedetomidine-Lignocaine nebulisation in awake fibreoptic nasal intubation.
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
- Registration Number
- CTRI/2022/07/043953
- Lead Sponsor
- Dr Asmita Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients giving written consent
Patients of either sex
Patients belonging to ASA grade I and II
Patients with anticipated difficult intubation
Exclusion Criteria
Patient refusal.
Patient with pregnancy, known alcoholic or drug abuser, or on chronic opioid therapy.
Patient belonging to ASA grade IiII and above.
Patients having hypersensitive reaction to drugs involved in the study.
Patients with bradycardia, any atrioventricular block, heart failure, having significant neurological, hepatic,renal, and pulmonary disease.
Patients undergoing emergency surgeries.
Patients with psychiatric illness.
Contraindication for nasal intubation like thrombocytopenia or coagulopathies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method